Skip to main content

Table 2 Value of borderline resectability

From: Opinions and use of neoadjuvant therapy for resectable, borderline resectable, and locally advanced pancreatic cancer: international survey and case-vignette study

 

surgeons

oncologists

What does borderline resectable mean to you?

 The primary tumor can only be resected by surgeons with particular expertise

26/99 (26.3%)

2/15 (13.3%)

 The resection of the primary tumor inherits a high risk for (incomplete) R1 resection

73/99 (73.7%)

13/15 (86.7%)

 The tumor can be resected R0, but the oncological outcome after surgery is questionable

16/99 (16.9%)

1/15 (6.7%)

 The morbidity of a resection of the primary tumor exceeds the normal morbidity by far

9/99 (9.1%)

 Is not important – either a tumor is resectable or not

2/99 (2%)

What defines borderline resectability?

 Tumor contact to the portal (PV)/superior mesenteric (SMV) veins on imaging – likelihood of a PV/SMV resection

29/99 (29.3%)

8/15 (53.3%)

 Tumor contact to the hepatic or mesenteric arteries on imaging

35/99 (35.4%)

4/15 (26.7%)

 Tumor contact to the PV/SMV up to 180° on imaging

31/99 (31.3%)

6/15 (40%)

 Tumor contact to celiac, hepatic or mesenteric arteries up to 180° on imaging

43/99 (43.4%)

5/15 (33.3%)

 Tumor contact to the PV/SMV of more than 180° on preoperative imaging

40/99 (40.4%)

5/15 (33.3%)

 Tumor contact to the celiac/hepatic or superior mesenteric arteries of more than 180° on imaging

19/99 (19.2%)

 Tumor related portal vein thrombosis on imaging

16/99 (16.2%)

 Resectability cannot be assessed on imaging only

12/99 (12.1%)

1/15 (6.7%)

 others

9/99 9.1%)